Primary hrHPV DNA Testing in Cervical Cancer Screening: How to Manage Screen-Positive Women? A POBASCAM Trial Substudy

Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-13-0173
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Using Communication to Manage Uncertainty About Cervical Cancer Screening Guideline Adherence Among Appalachian Women

Journal of Applied Communication Research
CommunicationLanguageLinguistics
2016English

Screening for Prostate Cancer: How to Manage in 2006

Acta chirurgica iugoslavica
2005English

By How Much Could Screening by Primary Human Papillomavirus Testing Reduce Cervical Cancer Incidence in England?

Journal of Medical Screening
Health PolicyPublic HealthOccupational HealthEnvironmental
2016English

O10.3 Predictors of Women’s Intentions to Receive Cervical Cancer Screening With Primary HPV Testing

Sexually Transmitted Infections
DermatologyInfectious Diseases
2013English

Complementarity Between miRNA Expression Analysis and DNA Methylation Analysis in hrHPV-positive Cervical Scrapes for the Detection of Cervical Disease

Epigenetics
Cancer ResearchMedicineMolecular Biology
2019English

Cues to Cervical Cancer Screening Among U.S. Hispanic Women

Hispanic Health Care International
Nursing
2016English

HPV-based Cervical Cancer Screening in Nicaragua: From Testing to Treatment

BMC Public Health
EnvironmentalPublic HealthOccupational Health
2020English

How Might HPV Testing Be Integrated Into Cervical Screening?

The Lancet Oncology
Oncology
2012English

Routine Cervical Screening by Primary HPV Testing: Early Findings in the Renewed National Cervical Screening Program

Medical Journal of Australia
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy